Pura Vida Investments’s Aravive, Inc. Common Stock ARAV Stock Holding History

Pura Vida Investments’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-17	Closed	–	–	108
2017 Q3	$0	Buy	+17	New	+$1.72K	﹤0.01%	100

Other funds holding ARAV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pura Vida Investments's ARAV Position: Q4 2017 in Review

Pura Vida Investments sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2017, closing a stake of 17 shares.

Pura Vida Investments first reported a position in ARAV in Q3 2017 and held it in 1 quarter. The position peaked at $0 in Q3 2017. 85 funds tracked by Wall St. Rank hold ARAV as of Q4 2017.

Pura Vida Investments reported no remaining Aravive, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Pura Vida Investments sold 17 Aravive, Inc. Common Stock shares in Q4 2017.
Pura Vida Investments first reported a position in Aravive, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
Pura Vida Investments's Aravive, Inc. Common Stock position peaked at $0 in Q3 2017.
85 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2017.

Based on Pura Vida Investments's 13F filing for Q4 2017, filed 14 Feb 2018.